US Broker Ratings

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 27% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Gem with a 25% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leader in the healthcare diagnostics and research sector, offers a compelling opportunity for investors seeking growth in the medical imaging space...

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring the 3.39% Potential Upside in Biotech Innovation

For investors with an eye on the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) stands out as a compelling prospect. With its focus on tackling serious..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 7.43% Potential Upside Amidst Industry Challenges

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a fascinating investment opportunity. With a market capitalization of $7.65..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 22% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS), a cornerstone in the healthcare sector, presents an intriguing opportunity for investors looking to capitalize on the burgeoning medical care..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring Growth Potentials with Robust Buy Ratings

Revolution Medicines, Inc. (RVMD), a key player in the biotechnology sector, is making waves in precision oncology with its innovative approach to targeting RAS-addicted cancers. Headquartered..

Exelixis, Inc. (EXEL) Stock Analysis: A Healthcare Giant with a 3.03% Upside Potential

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has been making waves with its innovative contributions to oncology treatments. Headquartered in Alameda, California,..

Regencell Bioscience Holdings L (RGC) Stock Analysis: What Investors Need to Know About This $15.53 Billion Market Cap Healthcare Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is capturing the attention of investors with its unique position in the healthcare sector, specifically in the specialized field of..

BrightSpring Health Services (BTSG): Analyst Ratings Signal Strong Buy Amid 9.71% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a key player in the U.S. healthcare sector, is capturing investor attention with its robust growth trajectory and favorable analyst ratings...

Bio-Techne Corp (TECH) Stock Analysis: Navigating a 2.7% Potential Upside with Strong Buy Ratings

In the dynamic world of biotechnology, Bio-Techne Corp (NASDAQ: TECH) emerges as a compelling investment with a robust market presence and a strategic focus on innovation...

Soleno Therapeutics (SLNO) Stock Analysis: Unveiling a Potential 164% Upside in the Biotech Arena

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a compelling prospect of a 164.22% upside potential, as indicated by the average analyst target price...

Chemed Corp (CHE) Stock Analysis: Exploring a 24.34% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Chemed Corporation (NYSE: CHE) presents a compelling opportunity. Operating primarily in the United States, Chemed delivers..

Axsome Therapeutics (AXSM) Stock Analysis: Navigating a 13% Upside Potential in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a key player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS) disorders...

TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking the 32% Revenue Growth and Investor Ratings

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry, as it continues to redefine organ transplant therapies...

Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics Giant’s Growth Amid Market Challenges

As investors seek promising opportunities in the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case with its robust market presence and innovative product offerings...

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 100.75% Potential Upside in Biotech Investment

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector with its innovative approach to medicinal therapies. With a market capitalization of $12.28 billion,..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth with a 2.42% Potential Upside

Becton, Dickinson and Company (NYSE: BDX) represents a cornerstone in the healthcare sector, consistently proving its mettle in the competitive landscape of medical instruments and supplies...

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 19% Upside with Strong Buy Ratings

For investors with an eye on the burgeoning field of oncology, BeOne Medicines Ltd. (ONC) presents a compelling opportunity. Operating out of Switzerland, this biotech heavyweight..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and Promising Genetic Medicine Pipeline

Krystal Biotech, Inc. (NASDAQ: KRYS) stands at the forefront of the biotechnology sector with its innovative approach to genetic medicine. Headquartered in Pittsburgh, Pennsylvania, the company..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 43.77% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is carving out a prominent niche in the biotechnology sector with its focus on innovative treatments for B-cell mediated diseases. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds